The British Veterinary Association has given a cautious welcome to the merger of the Animal Health Agency (AH) and the Veterinary Laboratories Agency (VLA) announced yesterday by Secretary of State Caroline Spelman.
Professor Bill Reilly, President of the BVA said: "On the face of it there could be significant benefits in merging these two key animal health organisations. Already, at local and national levels, the two agencies are required to work closely and if done properly we could have one body that is completed committed to animal health.
"However, every veterinary surgeon will want reassurance that the merger will not simply become another way to cut costs by reducing the number of people working on disease surveillance and research. It is vital that both organisations continue to deliver under the new body.
"The merger could have an impact on responsibility and cost sharing plans, the tendering exercise for Official Veterinarian (OV) work, and the future of animal health delivery in the devolved administrations. The BVA is therefore calling for a wide consultation on how the merged organisation will work to ensure the best for the veterinary profession, farming community and all other interested organisations."
The Blue Cross and National Veterinary Services (NVS) are celebrating the success of a new initiative to generate additional saleable items for the charity, with the help of vet practices across the UK.
Earlier this year, The Blue Cross teamed up with NVS to launch a campaign to sign up vet practices who use NVS services to encourage their staff and clients to donate bags of unwanted clothes and bric-a-brac for the charity to sell and raise funds. This week saw the arrival of the 5,000th bag of donated items arrive at The Blue Cross warehouse
Jonathan Chambers Blue Cross spokesperson said: "We are extremely grateful to NVS, the vet practices taking part in the scheme and their clients. We are overwhelmed at the response so far and looking forward to receiving many more bags of goods in the future. Although the donated items may be unwanted possessions to some, each bag generates about £20 of income for us. This means the scheme has so far provided an amazing £100,000 worth of income towards helping sick and homeless animals in the care of The Blue Cross."
Caitrina Harrison, Sales & Marketing Director for NVS said: "We are delighted to be supporting The Blue Cross with this worthwhile initiative. We have an experienced and flexible logistics team, who have been able to help with the delivery and collection of the clothing bags throughout the UK. We have had excellent feedback from many veterinary practices who have got involved and the requests for clothing bags keep coming in."
Veterinary practices who receive their stock and drugs from NVS that are not yet part of The Blue Cross donation scheme can sign up now by contacting julie.godwin@nvs-ltd.co.uk or Jonathan Chambers at The Blue Cross: trading@bluecross.org.uk.
Organisers of The Vet Charity Challenge, which last year raised £50,000 for charity, have announced that the event will take place Saturday 27th September 2014 in Pewsey, near Marlborough, Wiltshire.
The event consists of teams of four walking/running, cycling and kayaking as well as some orienteering and mental and physical tasks.
Registration will open at the start of April. Organisers say that spaces are limited and in 2013 filled up very fast, so early booking is advisable.
The charities being supported in 2014 will be Hearing Dogs for Deaf People, SPANA and Cats Protection.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse and Vetoquinol and supported by the VMPA and Veterinary Practice magazine.
For more information visit www.vetcharitychallenge.co.uk.
Elanco Animal Health has launched an updated Atopica Comfort Club, a support initiative for veterinary professionals treating either canine atopic dermatitis or feline allergic dermatitis cases with Atopica.
The Atopica Comfort Club loyalty scheme now has a new website which enables all members of the practice team to see the cases being managed and the offers available for new and existing users post diagnosis. The initiative provides veterinary practices with a free of charge Atopica redemption scheme through both induction and maintenance periods.
Elanco says the new website will also enable veterinary practices to view and redeem offers instantly, receive reminders about offers and updates together with emails to confirm offers have been redeemed and the products despatched.
Alice Laurens, DVM MRCVS, Dermatology Marketing Manager at Elanco Animal Health, said: “The Comfort Club loyalty scheme embraces a multi-modal approach and ensures better comfort is provided to Atopica patients with options to offer a flea product, shampoo, essential fatty acids and an adapted diet.”
To support the new Atopica Comfort Club loyalty program, Elanco has also produced a ‘practice log book’ to enable vets to record details on each case which can then be entered onto the Comfort Club website.
For further information, or to book a lunch and learn meeting, please contact your local Elanco Animal Health key account manager or email elancoCAH.uk@elanco.com.
VetViewer is currently used by over 400 small animal, mixed and equine practices in the UK to track their metrics.
The tool also allows users to run simulations - so for instance if the practice has had to stop offering routine consults, or has a reduced number of vets or RVNS available, they can immediately see the impact on the practice top line.
VetViewer can be used by all practices, independent or corporate, or individual branches. It can track performance for the past 18 months, allowing comparisons to be made with before, during and after the COVID-19 outbreak.
VetViewer Director, Alex Arpino, says the service usually helps practices to thrive but right now offers potential to help them survive: "Many clinics are struggling to know what to do for the best and not knowing the magnitude of the economic impact of their decisions doesn't help.
"Everyone wants to protect their staff but also ensure they have jobs to return to. We can link data from nearly every PMS in the UK to VetViewer and the practice's management team is given access to a portal where they can see the data at a glance. Right now, being able to run simulations is central to current and future planning and could help alleviate stress for many practices managers and owners."
In normal circumstances, VetViewer allows practices to look at their performance over time and the effect of any changes they might make. The company says it can also help practices evaluate where they over and under-perform relative to their region and the UK as a whole.
The data available in VetViewer includes income from food, wormers and flea treatments and other provisions that many practices might find ways to sustain in the coming weeks.
Looking forward to a time when isolation and distancing can be lifted, the tool also shows where there is potential for practices to increase income - whether that's because they are under-charging for consults compared to the regional average, or performing fewer neutering procedures, or under-utilising potential diagnostic or imaging aids.
Such information is likely to be vital to recovery, providing a clear indication of the speed of recovery and the services that are making the biggest contribution to that recovery.
The VetViewer service can be demonstrated remotely by the company's dedicated team of Business Development Managers and the service can be activated at a distance, so practices can set up their account quickly and without any costs, either to set up or maintain.
For more information, visit: www.vetviewer.co.uk / www.veterinaryinsights.com or practice owners or managers can telephone 01403 800135 to make an appointment for an online meeting or to find out more.
The role was created last November when the Animal & Plant Health Agency (APHA) started allowing para-professional staff to support vets in carrying out TB testing in England.
UK Farmcare says there are now 49 fully authorised ATTs in England with another 21 TB testing under veterinary supervision and three undergoing the theory part of the training.
To become an ATT, applicants must be at least 18 years old, hold a valid UK driving licence and passport, possess a clean criminal record and then be approved by the APHA. Applicants also need at least three graded GCSEs or equivalent in English, Maths and a science or food production subject and at least six months cattle handling experience.
https://ukfarmcare.com/an-introduction-to-the-att-role.
The survey, which is being conducted in partnership with Hazlewoods accountants, will be used to provide anonymised benchmarking information to enable vets to compare their practice profitability and help identify areas where profitability could be improved.
The survey asks questions around a range of reporting figures including gross profit margin, staffing cost levels and EBITDA (Earnings before interest, taxes, depreciation, and amortisation), to allow for benchmarking in greater detail.
The anonymised benchmarking results of the survey will be free to all participants, including non SPVS members.
SPVS members will receive the benchmarking results together with supporting commentary.
The deadline for completion is 4th November 2022.
https://spvs.org.uk/spvs-profitability-survey
Typically, diagnosis of endocrine disease is based on a thorough history and physical examination, followed by laboratory tests.
However clinical signs vary substantially across animals with endocrine disorders, so this new app uses AI and big data from millions of dogs in the RVC VetCompass database to improve the chances of an accurate diagnosis.
Dr Dan O’Neill, Associate Professor for Companion Animal Epidemiology at the RVC, said: "By applying the latest AI technology, the app is designed to assist primary care veterinary surgeons to better detect and diagnose Cushing’s Syndrome.
"The app provides a guide to the probability of Cushing’s syndrome as an explanation in patients showing both typical and atypical clinical signs for Cushing’s"
The app is free to download on both Apple and Android devices in the UK and EU countries by searching for 'the endocrinology app".
Parasitologists from ESCCAP (European Scientific Counsel Companion Animal Parasites) have been voicing their concern over the implications of the imminent changes to the UK's DEFRA-run Pet Travel Scheme (PETS).
Under the new regulations, which take effect from Jan 2012, tick control will no longer be mandatory. According to ESCCAP, a recent study has demonstrated that a population of exotic tick species has already become established in the south-east of England1. With up to 15,000 animals travelling under PETS each month, the possibility of exotic ticks (and their associated tick-borne diseases) entering and establishing in the UK becomes increasingly likely. The European Parliament has yet to rule on mandatory tapeworm control. The decision will impact on the future distribution of, and disease threat from, Echinococcus multilocularis.
ESCCAP UK is advising all veterinary surgeons to discuss the risks with their clients and to ensure they make an informed decision about tick control when the new legislation comes into effect.
In addition, the UK branch of ESCCAP is holding a free seminar in Bristol on 28th October to highlight the role that veterinary practices can play in helping clients understand how the changes could impact upon their pet's health.
ESCCAP says the seminar will provide all the information clinicians need to have an informed dialogue with clients. Presentations will provide an overview of the impact of the changes to PETS in relation to rabies, Echinococcus and ticks, as well as advice about how to communicate the information to pet owners and the tools and support available.
Additional support includes ESCCAP UK's website http://www.esccapuk.org.uk/, which offers updates on the PETS situation, guidelines for parasite control programmes and podcasts for veterinary surgeons, nurses and pet owners.
The seminar takes place at Engineers' House, The Promenade, Clifton Down, Bristol BS8 3NB.
To register, telephone: 01684 568998, or email: info@esccapuk.org.uk
Reference1. Smith F D, Ballantyne R, Morgan E R, Wall R (2011) Prevalence, distribution and risk associated with tick infestation of dogs in Great Britain. Medical and Veterinary Entomology. doi: 10.1111/j.1365-2915.2011.00954.x
The new reader is compatible with all ISO 15-digit (FDX-B) identification microchips. It features an integrated LCD screen that displays microchip numbers in a large, easy-to-read format and it also reports the temperature of temperature-sensing microchips.
Sureflap says the reader is lightweight, ergonomically designed, fits easily into the hand and is easy to operate. The company also says that its small size makes it less intimidating for pets.
Dr Nick Hill, managing director of SureFlap said: "The SureSense Microchip Reader was developed following feedback from veterinary and shelter staff that they often had to share microchip readers.
"The reader is our first professional product, developed exclusively for veterinary professionals, shelters, breeders and pet care professionals. Its affordability and size will ensure that it is possible to have multiple readers in each veterinary practice and shelter."
For further information, contact your wholesaler or the SureFlap team on 0800 9127 114 or via email vet@sureflap.com.
In the study titled “Evaluation of urethral orifice cross-section dimensions following perineal urethrostomy in male cats”, 24 male cats with lower urinary tract disease underwent the procedure. The urethral orifice cross-section was estimated by the largest urinary catheter that could be easily inserted through the stoma at three time points: preoperatively, intra-operatively and 12 days postoperatively. Cases of obstruction recurrence and stricture were documented within the six month follow up period.
Uri Segal, corresponding author for the paper, said: “The intraoperative stoma ranged from 1 to 10 (median 10) Fr and the 12-day postoperative stoma ranged from 4 to 10 (median 8) Fr. There was significant reduction of stoma size 12 days postoperatively, compared to the measurements taken intraoperatively.
"Postsurgical stricture formation and re-obstruction was documented in five of 24 (21%) of cats. Obstruction recurrence is probable if the intra-operative stoma size is 8 Fr or less. Furthermore, if the stoma size is 6 Fr or less, re-obstruction is almost certain (all of these cases in the study were re-obstructions). Conversely, an intra-operative stoma of more than 8Fr had a low risk of recurrence.”
Nicola Di Girolamo, editor of JSAP said: “These findings may function as a guiding rule for surgeons performing perineal urethrostomy, by providing an intraoperative measure of how likely re-obstruction and stricture formation is to occur. It should be remembered, however, that the functional urethral stoma cross-section may vary during the urination cycle and the measurements in this study are likely to only represent a fraction of the functional urethral cross-section size.”
The full article can be found in the August issue of the Journal of Small Animal Practice. It can also be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13148
Reference
Kruuse has announced that it is now the exclusive veterinary distributor in the UK, Europe, Australia and New Zealand for Nurtured Pets' Anti-LickStrip pet plaster, a natural hypo-allergenic adhesive plaster that deters licking, biting and chewing.
Anti-LickStrip's plaster is made with active ingredients including cayenne pepper, oregano, lemon powder and peppermint that acts as a deterrent to the animal when sniffed, licked or bitten. The veterinary range of Anti-Lick products will be co-branded under the Kruuse 'Buster' brand as: Buster Anti-LickStrip (sizes: small, medium and large) Buster Anti-LickStrip Pro and Buster Anti-LickStrip Pro C.
Andrew Groom, Managing Director, Kruuse UK Ltd. said: "This agreement further expands Kruuse's small animal product portfolio with its customer in Scandinavia, mainland Europe and the UK; increasing the already extensive range of animal tamper deterrents available to the veterinary practitioner."
Lisa Huntsman, President, Lauren Manufacturing & Nurtured Pets said: "This exciting partnership will further expand our products presence within the veterinary industry expanding our delivery of focused health and wellness products to customers, using Kruuse's strong relationships within veterinary practices."
Paul Aldrige MRCVS has won £2000 from Hill's Pet Nutrition after removing a cluster of uroliths from the bladder of an English bulldog.
He won the prize after sending the uroliths to the Minnesota Urolith Center to participate in a competition sponsored by Hill's UK in support of the launch of new Prescription DietTM c/dTM Reduced Calorie for cats.
Hill's says that although the winner was a canine patient this time, it was good news for the Bulldog that the sample was sent in, as the uroliths in question were found to contain urate. Purine uroliths, including urate, accounted for 6.4% of uroliths submitted to the Minnesota Urolith Center between 1981 - 20071. Staff at Center said that urate uroliths can vary in size, color, and texture: "This particular sample represents a good example of the need to submit uroliths for quantitative analysis. Physical appearance alone is insufficient to characterise mineral composition."
English bulldogs are one of the 66 breeds identified by the Minnesota Urolith Centre known to be affected by urate urolithiasis. Hill's says that foods such as its Prescription DietTM u/dTM can be used to help reduce the risk of uroliths recurrence in the future. Sara Locke, Hill's Associate Marketing Manager said: "We were very pleased to award the prize to Paul and congratulate him on being instrumental in producing such a successful outcome for his patient. Accurate urolith analysis is key. In many cases, these results enable vets to make accurate dietary recommendations that improve the long term prognosis for the patient."
The urolith analysis service is subsidised in part by an educational gift from Hill's Pet Nutrition and is provided to veterinary surgeons at no charge. You can download forms to submit a sample of uroliths at www.hillspet.co.uk/urolith or www.hillspet.ie/urolith or by calling Hill's on 0800 282438 or ROI 1800 626002."
Small Animal Clinical Nutrition, 5th Edition, Hand, Thatcher, Remillard, Roudebush, Novotny, p833
A new study published this month in the Equine Veterinary Journal (EVJ)1 has concluded that toxins from the seeds of the sycamore tree (Acer pseudoplatanus) are the likely cause of Atypical Myopathy (AM) in Europe.
However, to avoid confusion, the authors of the study point out that the American Sycamore (also just called 'the sycamore' in the USA), is a completely different species: Platanus occidentalis. Furthermore, the sycamore found in the UK is also known as the sycamore maple in other countries.
The new research follows on the heels of a study in the USA earlier this year that linked toxins from the box elder tree (Acer negundo) with Seasonal Pasture Myopathy (SPM), the US equivalent of AM2. The discovery marks an important step for the future prevention of this fatal disease.
Atypical Myopathy is a highly fatal muscle disease in the UK and Northern Europe. In ten years, approximately twenty European countries have reported the disease. Incidences tend to occur repeatedly in the autumn and in the spring following large autumnal outbreaks. Horses that develop AM are usually kept in sparse pastures with an accumulation of dead leaves, dead wood and trees in or around the pasture and are often not fed any supplementary hay or feed. SPM is a very similar disorder, prevalent in Midwestern USA and Eastern Canada that is now known to be caused by the ingestion of hypoglycin A, contained in seeds from the box elder tree.
The new European research1 was conducted by an international team led by Dominic Votion, University of Liege and involved 17 horses from Belgium, Germany and The Netherlands, suffering from Atypical Myopathy. High concentrations of a toxic metabolite of hypoglycin A, were identified in the serum of all of the horses. The pastures of 12 of the horses were visited by experienced botanists and the Acer pseudoplatanus, the sycamore maple, was found to be present in every case. This was the only tree common to all visited pastures.
Researchers believe hypoglycin A is the likely cause of both AM in Europe and SPM in North America. The sycamore and the box elder are known to produce seeds containing hypoglycin A and the pastures of the afflicted horses in Europe and the USA were surrounded by these trees.
Hypoglycin-A is found in various levels in the seeds of plants in the genus Acer as well as in various other genera in the family Sapindaceae such as ackee (Blighia sapida). In ackee, hypoglycin-A levels do vary with ripeness of the fruit and, if the fruit is eaten before it is mature, it causes hypoglycaemia to different degrees including a condition called "Jamaican vomiting sickness" (because of ackee's use in Jamaican cooking) and occasionally death in humans.
Researchers at the Universities of Minnesota2 and Liege are continuing their work to try to uncover exactly how the equine disease occurs. Dr Adrian Hegeman of University of Minnesota said: "It is likely that the most important contributing factors to horses becoming poisoned by hypoglycin-A are the availability of seed in the field combined with lack of other feeding options. The seeds from two species of maples (box elder and sycamore maples) that we have tested include significant quantities of hypoglycin-A.
"We know that seeds contain highly variable quantities from seed to seed, even within a single tree. We do not know yet how hypoglycin-A levels vary seasonally, nor do we know how its abundance varies with different levels of stress to the plant, though this may well explain seasonal variability in the occurrence of the malady. It is possible that conditions that stress the plants may contribute to significant seasonal changes in hypoglycin-A levels. At this point we just don't know. It is common held knowledge that trees under stress usually produce more seed."
Dr Jeff Gillman of University of Minnesota said: "Without question, further analysis of the seeds and other tissues from Acer species needs to be performed along with sampling of plant materials over multiple seasons and at various stress levels. Additionally, one cannot rule out more complex explanations for the seasonality of disease occurrence such as: animals may begin feeding on seed materials in response to depletion of more palatable choices under drought conditions; or simple explanations such as high wind events driving seeds into fields. These sorts of explanations for the occurrence of the disease do not depend on botanical variations in toxicity across seasons, sites or stress levels, yet also require consideration.
"Although limited examples are available, the experience of animals at a pasture site might also confer some degree of behavioral resistance to poisoning due to exposure at sub-lethal levels with prior exposure to seeds in the pasture."
Professor Celia Marr, Editor of Equine Veterinary Journal said: "This is an important advancement in our understanding of what causes AM and how it can be prevented. In immediate practical terms owners can take prompt measures to avoid exposing their horses to sycamore seeds this autumn. Where horses are grazing in the vicinity of sycamore trees, it is imperative that they are provided with sufficient supplementary feed as this will minimise the risk that horses might be tempted to ingest seeds containing this toxin. This must be done carefully and leaving wet hay on the ground should be avoided so providing extra carbohydrate feeds may be more practical."
References
According to Intervet, a study undertaken in Germany last summer has proven the efficacy of Butox SWISH at killing the midges responsible for carrying the bluetongue virus, when applied monthly to cattle. The study showed that even brief contact between a midge and hair from a treated animal killed midges rapidly for up to four weeks post-treatment.
The standard dose, applied in the usual way (on the neck and topline of the animal) delivers full-body coverage of Butox SWISH’s deltamethrin, helped partly by its unique micronised formulation. The product is also highly lipophilic which means it binds onto the natural oil secretions of the coat helping to improve coverage.
The trial used six heifers (each weighing around 400kg) treated with 30ml Butox SWISH (the standard fly dose and method of application). Two un-treated heifers were also studied for comparison.
During the five week period, contact between midges and treated hair caused immediate paralysis, and the midges then died at varying intervals depending on contact time and the number of days post-treatment with Butox SWISH. The trial verified the application of Butox SWISH monthly at the standard dose for cattle.
Trial director, Professor Mehlhorn suggested that producers should be prepared to reduce vector contact by removing their breeding habitats and combining this with the use of a knock-down treatment like Butox SWISH, which is the only product of its type which has proven efficacy against midges. Used in conjunction with vaccination, these measures may not stop the disease entering the herd, but will help reduce the spread of disease.
Lohmann Animal Health has launched AviPro IBD Xtreme vaccine against Infectious Bursal Disease — also known as Gumboro Disease — in broilers, commercial layers and breeders.
According to Lohmannn, it is highly effective against the vvIBDV (very virulent IBD virus), it breaks through high levels of maternal antibodies, and controls mortality with no loss of flock performance.
Since the 1980s the acute form of IBD has caused significant economic loss to the poultry industries in several countries. The vvIBDV, a more aggressive form first described in Europe in 1986, is now widespread throughout the world and can cause losses of 30-60 per cent in layers and 5-25 per cent in broilers.
Chicks are most susceptible between one and six weeks. Early in their lives they are protected by maternally-derived antibodies (MDAs), but these antibodies will neutralise live IBD vaccines when they are given too early. However, being highly invasive, the AviPro IBD Xtreme vaccine is able to overcome these MDAs so can be given earlier to provide greater protection from an early age.
Exact timing of vaccination depends primarily on the level of MDAs and the breakthrough titre of the vaccine on the one hand, and the virulence of the field virus and infection pressure on the other.
When compared with four of its main competitors in a trial with SPF birds AviPro IBD Xtreme outperformed them. It had the highest number of sero-positive birds, the highest mean ELISA-antibody titre seven days after vaccination and the best protection against clinical symptoms and mortality after a challenge with vvIBDV,” commented Brigitte Othmar, regulatory affairs manager at LAH.
“With the addition of AviPro IBD Xtreme, Lohmann Animal Health has now completed its range of live IBD vaccines and is able to provide its customers with the appropriate solution for any Gumboro problem,” she added.
AviPro IBD Xtreme can be applied via the drinking water or eye-drop and is presented in vials of 1,000 and 2,500 doses.
More information on this vaccine can be found on the Lohmann Animal Health website http://www.lah.de/.
Fort Dodge Animal Health has announced it is working with the authorities to put measures in place to make its West Nile Virus vaccine, licensed in the United States, available to the European equine market. These measures will ensure a vaccine is readily available in the event of an outbreak in the UK.
This news comes as the Zooprophylactic Institute of Teramo, the Italian National Reference Centre for Exotic Diseases, has confirmed an outbreak of WNV among horses in stables in the northern province of Ferrara. About 20 horses are believed to have been affected.
Fort Dodge was the first company to develop and fully license a vaccine to protect horses against this potentially deadly disease. An inactivated whole virus vaccine, it was the only vaccine available in the United States at the height of the 2002 outbreak, which affected 15,000 horses. The U.S. Department of Agriculture credited the vaccine with contributing to the 70 per cent decline in U.S. equine West Nile cases since the height of the outbreak. WNV is now considered endemic in all areas of North America.
"As this latest outbreak of WNV in Italy highlights, the disease presents an increasing threat to the equestrian sector in Europe," says Helen Barnes, EMEA Equine Business Manager for Fort Dodge. "With little current natural immunity among the equine population, the consequences of a major outbreak could be devastating."
"Until now, horse owners in Europe have perhaps believed WNV is not a disease they should be concerned with but the outbreak in Ferrara came out of the blue, and at a time when a human case of WNV was also reported in the same province. This situation of both human and equine cases being reported is identical to that seen in the outbreaks in the United States. It's a stark reminder of the challenge this disease poses, particularly as environmental factors, such as global warming and heavy rains threaten to create mass breeding grounds for mosquitoes," says Barnes.
"Our experience with WNV in the United States has given us an exceptional understanding of the disease and the importance of vaccination. We now look forward to working in partnership with the European governments, the EU Commission and the veterinary community across Europe to help build understanding and knowledge of this dangerous emerging disease threat."
The RCVS is to hold an online hustings on Tuesday, 19 March at 7pm to help voters decide who they wish to vote for in the upcoming RCVS Council elections, and is inviting members of the veterinary profession to suggest questions for the candidates to answer.
Gordon Hockey, RCVS Registrar said: "From feedback we've received, one of the reasons why people don't vote is because they know little about the candidates or their views. We hope this hustings will provide the candidates with a platform to address the veterinary electorate directly, and give voters the chance to put their own questions to those hoping to serve on Council."
The hustings will be run as a live webinar by 'The Webinar Vet' and will be free to listen to. However, the College says that due to the high number of candidates standing for election, it isn't possible to hold a debate, so questions should be submitted in advance (see below). Each candidate will be allocated around three minutes to introduce themselves and answer up to three questions of their choosing. The whole event will run for just under an hour.
Anthony Chadwick, who runs The Webinar Vet, will moderate proceedings, and Gordon Hockey will be on-hand to address any factual inaccuracies.
Veterinary surgeons can register to listen to the hustings at www.thewebinarvet.com/rcvs and submit their questions at the same time; alternatively, questions can be emailed to Ian Holloway at the RCVS (i.holloway@rcvs.org.uk).
Questions should be relevant to the role of the RCVS and the role of Council Members (see www.rcvs.org.uk/about). If questions should remain anonymous, please say so.
Ballot papers and candidates' biographies and manifestos are due to be posted on 7 March. Votes may be cast online, by text message or by post, by 5pm on Friday, 26 April 2013.
RCVS Knowledge says it first identified the need for an open access and easily accessible means of distributing veterinary evidence in early 2014. The concept for a new digital journal was announced at the 2014 EBVM Network Conference, and began with the mission statement of improving front-line clinical standards, funded initially by a donation from the RCVS.
In its first year Veterinary Evidence has published 58 papers which have been downloaded over 34,000 times by an international audience spanning 20 countries. It has also streamlined its submission process and added a range of new tools and resources. The tools include a downloadable submission template and a range of checklists and guidelines to help the practitioner conduct evidence-based medicine.
Looking to the future, the charity says that its website platform will be overhauled later in 2017, so practitioners can find articles quickly and implement their findings in practice.
RCVS Knowledge is now running a survey to find out what topics you'd like to see covered by Veterinary Evidence. All participants will entered into a draw for a new iPad.
Veterinary Evidence is also on the hunt for a new Editor-in-Chief, to move the journal into its next chapter. The Editor-in-Chief will have a passion for EBVM and engaging with the veterinary community and will help provide readers with the content they need. If you’re interested in applying for this role you can view the full job description here.
The Teaching Excellence Framework (TEF) was introduced by the Government to build evidence about the performance of the UK’s higher education sector, with an analysis of teaching and learning outcomes.
Universities, colleges and alternative providers of higher education voluntarily took part in the TEF, and each provider was rated Gold, Silver or Bronze, or received a Provisional award where there was not enough data for a full assessment.
The TEF awards were decided by an independent panel of experts who measured excellence in three areas: teaching quality, the learning environment and the educational and professional outcomes achieved by students.
Professor Stuart Reid, Principal of the RVC, said: "I am delighted that the award of TEF Gold endorses and builds upon the RVC’s recognition as a global leader in veterinary education. As the only independent, internationally accredited school that offers education for the whole veterinary team, a commitment to delivering quality teaching is at the core of our business. The TEF Gold award is peer recognition that we meet the highest of standards, an achievement of which we can be justifiably proud."
The survey for vets is about two minutes long: www.smartsurvey.co.uk/s/ZCONJA/.
A prize draw will be carried out after the survey closes with 10 participants winning a Q fever snood.
Renzo Di Florio, veterinary advisor at Ceva Animal Health, said: “Despite Q fever being endemic in GB dairy herds1, we believe that awareness amongst farmers and the related farming industries is low.
"Our national Q fever surveys will help us ascertain how we can support farmers and vets when it comes to diagnostic challenges, treatment options and prevention through vaccination to help protect farmers, farming families and the related professions from the disease and reduce the impact of Q fever on farms.”
Jonathan Statham MA VetMB DCHP FRCVS, a RCVS registered specialist in cattle health, co-author of the ‘Dairy Herd Health’ textbook and chief executive of RAFT Solutions, added: “Multiple surveys in the UK support Q fever prevalence ranging from 60 to 80% in our national dairy herd, including recent work carried out by RAFT Solutions in NE England and SW England (2021)2.
"Reproductive issues are of course multifactorial and it is important therefore not to associate a Q fever positive diagnostic result as a single cause of infertility.
"However, increased level of metritis and endometritis, abortion and pregnancy loss or extended calving-conception intervals merit further investigation with Q fever as part of a herd health discussion that should of course address other infectious disease such as BVD, IBR or leptospirosis.
"Q fever is of further significance as a zoonosis and also as a potentially emerging disease in the context of climate change and changing vector patterns.”
Ceva has also launched a social media toolkit containing social media graphics and content on the disease that can be posted on vet practice social media channels, available from your local Ceva account manager.
Equistro has introduced Legaphyton to its range of supplements. Legaphyton has been developed to support liver function. It incorporates a new and patented complex called Siliphos®.
Siliphos® is a complex of concentrated Milk Thistle fruit extract and phospholipids, and is a source of readily available carbohydrates important for liver support.
Milk Thistle (silymarin) extract has documented virtues in liver support and is rich in flavanoligan (Silybin), while phospholipids (phosphatidylcholine) maintain healthy liver cell membrane function and repair and are crucial for essential lipoprotein transport in the liver.
“The liver is one of the most important organs and performs more often than one realises,” said Val Day, Equistro’s product manager. “Legaphyton has been introduced to give an extra boost to the horse’s liver function and help the liver fulfil its varied role.”
Equistro Legaphyton is available in 900g packs, which is sufficient for 30 days for a standard 500kg horse. Ask your Vetoquinol representative for more details or visit http://www.vetoquinol.co.uk/
.
CEVA Animal Health, manufacturer of D.A.P.® and Feliway®, has launched a new marketing toolkit to assist veterinary practices in educating and supporting clients with noise phobic pets in the run up to the fireworks' season.
The new firework pack features an A3 waiting room poster, a range of colourful notice board display materials, reminder stickers and a pack of educational client leaflets.
Lucy Brett, product manager at CEVA Animal Health said: "Research has revealed that over 49% of dogs in the UK have a fear of loud noises1, but only 50% of their owners will ask their vet for help2.
"Our new marketing toolkit will help veterinary practices remind their clients of the steps that can be taken to reduce firework fear and highlight the use of D.A.P.®, the only non-prescription product proven to reduce the intensity of fear suffered as a result of loud noises3."
As part of this year's awareness campaign, CEVA will be running a regional competition amongst veterinary practices for the best decorated waiting room.
Copies of the fireworks' marketing toolkit can be ordered from you local CEVA account manager or by calling CEVA Animal Health on 01494 781510.
This campaign follows the wildly publicised desensitisation campaign run earlier in 2009 and will include details about using the Sounds Scary CD from Sound Therapy 4 Pets.
Virbac - manufacturer of Effipro - has launched the 'Flea Free Zones' campaign to help practices fight back against retail competition in the flea control market.
The company says that with an on-pet flea product market estimated to be worth well in excess of £64 million, and an estimated 20 million cats and dogs in the UK, vets are well positioned to improve their revenues and provide excellent customer service, by promoting flea control to all of their customers.
However, according Dr Rachel Crowe, Effipro Product Manager, much of this business is currently going through retail channels: "Many pet owners have become used to purchasing their flea treatment from retail outlets, mainly due to cost, and no longer distinguishing between a brand bought from a vet and one bought from a supermarket.
"As a dedicated veterinary business, Virbac is focussed on supporting and increasing business within veterinary practices. Our 'Flea Free Zones' campaign is a practice support package designed to help promote initial purchase, as well as long-term client loyalty. We know that pet owners often turn to their vet or vet nurse for advice, but then purchase treatments elsewhere.
"With Effipro, practices have the performance of fipronil but at a highly affordable price, and we believe this promotion will help vets grow their share of the flea control market."
The campaign is designed to get clients purchasing flea treatments from their vet and encourage repeat purchases from the practice.
Dr Crowe said: "The beauty of Effipro is that it has a broad range of products, packs and price flexibility. In particular the single pipette from the Practice Pack is proving a very popular point of entry for the owner, especially as an initial trial purchase. Also included in the promotional campaign is an Effipro loyalty scheme, which provides an incentive to keep clients coming back and literature to assist practice staff to answer customer queries about flea control.
"Just one spot-on treatment range also means there is no confusion with POM-V alternatives, so loyalty to Effipro is easier to retain within the practice. And with the added option of purchasing award winning Indorex environmental insecticide spray, clients now have a complete flea control solution available from their vet practice. So with both products being supported by prominent promotional campaigns, there hasn't been a better opportunity than this for vets looking to capture a bigger share of customer spend on flea treatments."
To learn more about Virbac's Flea Free Zones campaign contact your local Virbac territory manager or call Virbac on 01359 243243.
The International Federation on Ageing has published Companion Animals and the Health of Older Persons, a report described as the most extensive literature review to date of research undertaken in the field of companion animals and the health of older people, made possible through an educational sponsorship from Bayer Healthcare.
The report provides a comprehensive literature review into the ways pets contribute to the physical and mental health of individuals and the well-being of our broader society, citing studies which found:
Dr Jane Barratt from the International Federation on Ageing said: "This field of research has important implications across generations and also for the future of our broader society. Many studies have broadly discussed how pets, such as dogs and cats, contribute to health by reducing anxiety, loneliness and depression, but until today, have not yet been published in a single resource. This new report advances our understanding of the value of companion animals in the framework of human health and the broader society."
In the report, investigators acknowledge that the current data on human-companion animal interactions are often predicated on anecdotal evidence and scant qualitative and quantitative data, with poorly-constructed and poorly-controlled study design. This may account in part for the conflicting results found in a number of different studies. Nonetheless, they argue that based on current evidence of considerable positive potential for the health of older individuals, and the associated health and welfare benefits for local communities and societies, more research time and energy should be directed towards this area of research. In particular, they say, there should be much greater involvement from veterinary surgeons, who are well placed to be consulted in studies of companion animals and older people’s attachment, affection and bonding capacities, well-being and social capital.
Ferenc Polz, Head of Bayer Animal Health said: "The therapeutic benefit of companion animals is an area of study attracting increasing interest among health and social science professionals and this sponsored report is yet another example of the life changing potential of human and animal relationships."